In light of our recent finding that inhibition of CXCR4/PLC-mediated signaling enhances Dex sensitivity in B-ALL cells [19], we hypothesized that defective metabolism and mitochondrial pathways may be associated with this mechanism. This evidence concerns the gene CXCR4 and acute lymphoblastic leukemia.